Cargando…
Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot Study
OBJECTIVE: Antinuclear antibodies (ANA) serve as screening tests for connective tissue diseases but have low specificity. In this pilot study, we aimed to identify patients with first-time positive ANA and musculoskeletal complaints and correlate serum soluble vascular adhesion molecules as biomarke...
Autores principales: | Oleszowsky, Mara, Seidel, Matthias F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816882/ https://www.ncbi.nlm.nih.gov/pubmed/29487871 http://dx.doi.org/10.1155/2018/8286067 |
Ejemplares similares
-
Antinuclear Antibodies
por: Frank, David A.
Publicado: (1984) -
Elevated Serum Levels of Progranulin and Soluble Vascular Cell Adhesion Molecule-1 in Patients with COVID-19
por: Yao, Shifei, et al.
Publicado: (2021) -
Serum levels of soluble platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 are decreased in subjects with autism spectrum disorder
por: Kameno, Yosuke, et al.
Publicado: (2013) -
Serum concentrations of soluble adhesion molecules in patients with colorectal cancer.
por: Velikova, G., et al.
Publicado: (1998) -
Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: multiplex analysis of serum markers
por: Chen, Vincent L., et al.
Publicado: (2017)